Merkel Cell Carcinoma News and Research

RSS
Researchers create first bona fide mouse model of Merkel cell carcinoma

Researchers create first bona fide mouse model of Merkel cell carcinoma

Merkel cell carcinoma has a higher post-treatment recurrence rate than other skin cancers

Merkel cell carcinoma has a higher post-treatment recurrence rate than other skin cancers

Direct-to-consumer machine learning model incorrectly classifies rare, aggressive skin cancers

Direct-to-consumer machine learning model incorrectly classifies rare, aggressive skin cancers

Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects

Penn Medicine and Wistar secure $11.7 million SPORE grant for three melanoma research projects

Creating hair-bearing human skin becomes a reality

Creating hair-bearing human skin becomes a reality

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

Patients with aggressive form of skin cancer can benefit from new type of immunotherapy

New study provides a better understanding of Merkel cell carcinoma

New study provides a better understanding of Merkel cell carcinoma

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients

Largest genomic analysis could help improve treatment for Merkel cell carcinoma patients

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Research finds rising trend in incidence of merkel cell carcinoma

Research finds rising trend in incidence of merkel cell carcinoma

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

U-M research reveals important clues about invasion of polyomaviruses

U-M research reveals important clues about invasion of polyomaviruses

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

NCCN Radiation Therapy Compendium adds nine new clinical practice guidelines in oncology

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

Immunotherapy drug becomes first FDA-approved treatment for metastatic MCC

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma